Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Genazzani

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Drugs in R&D|February 27, 2008
Difficulties in the production of identical drug products from a pharmaceutical technology viewpointArmando A Genazzani, Franco Pattarino
Trends in Pharmacological Sciences|April 1, 1997
A Ca2+ release mechanism gated by the novel pyridine nucleotide, NAADPA A Genazzani, A Galione
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 13, 2010
Dasatinib: is it all in the dose?Fabrizio Condorelli, Armando A Genazzani
Current Biology : CB|July 19, 2002
Calcium signalling: calcium goes globalArmando A Genazzani, Pete Thorn
The Biochemical Journal|May 1, 1996
Nicotinic acid-adenine dinucleotide phosphate mobilizes Ca2+ from a thapsigargin-insensitive poolA A Genazzani, A Galione
Biochemical and Biophysical Research Communications|December 22, 1999
Calcium controls the transcription of its own transporters and channels in developing neuronsE Carafoli, A Genazzani, D Guerini
Tumori|June 21, 2008
[Pharmacokinetic and pharmacodynamic features of palonosetron]Armando A Genazzani, Richard A Billington
Biochemical and Biophysical Research Communications|September 28, 2000
Characterization of NAADP(+) binding in sea urchin eggsR A Billington, A A Genazzani
Cell Calcium|November 7, 2006
PPADS is a reversible competitive antagonist of the NAADP receptorRichard A Billington, Armando A Genazzani
Trends in Pharmacological Sciences|April 5, 2002
NAADP: an atypical Ca2+-release messenger?Armando A Genazzani, Richard A Billington
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Drugs in R&D|February 27, 2008
Difficulties in the production of identical drug products from a pharmaceutical technology viewpointArmando A Genazzani, Franco Pattarino
Trends in Pharmacological Sciences|April 1, 1997
A Ca2+ release mechanism gated by the novel pyridine nucleotide, NAADPA A Genazzani, A Galione
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 13, 2010
Dasatinib: is it all in the dose?Fabrizio Condorelli, Armando A Genazzani
Current Biology : CB|July 19, 2002
Calcium signalling: calcium goes globalArmando A Genazzani, Pete Thorn
The Biochemical Journal|May 1, 1996
Nicotinic acid-adenine dinucleotide phosphate mobilizes Ca2+ from a thapsigargin-insensitive poolA A Genazzani, A Galione
Biochemical and Biophysical Research Communications|December 22, 1999
Calcium controls the transcription of its own transporters and channels in developing neuronsE Carafoli, A Genazzani, D Guerini
Tumori|June 21, 2008
[Pharmacokinetic and pharmacodynamic features of palonosetron]Armando A Genazzani, Richard A Billington
Biochemical and Biophysical Research Communications|September 28, 2000
Characterization of NAADP(+) binding in sea urchin eggsR A Billington, A A Genazzani
Cell Calcium|November 7, 2006
PPADS is a reversible competitive antagonist of the NAADP receptorRichard A Billington, Armando A Genazzani
Trends in Pharmacological Sciences|April 5, 2002
NAADP: an atypical Ca2+-release messenger?Armando A Genazzani, Richard A Billington
Pageof 24